This announcement is a separate document:
华东医药：关于全资子公司获得美国FDA新药临床试验批准通知的公告
Huadong Pharmaceutical: Announcement on Wholly-owned Subsidiaries Obtaining US FDA Clinical Trial Approval Notice for New Drugs
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated